Successful treatment of leflunomide-induced acute pneumonitis with cholestyramine wash-out therapy

Journal of Clinical Rheumatology

Volumn 15, Issue 8, 2009, Pages 389-392

  Wong, S P Y ^a   Chu, C M ^a   Kan, C H ^a   Tsui, H S ^b   Ng, W L ^a  

^a UNITED CHRISTIAN HOSPITAL   (Hong Kong)

^b Private Rheumatologist   (Hong Kong)

Author keywords

Adverse drug reaction; Cholestyramine wash out; Interstitial pneumonitis; Leflunomide

Indexed keywords

C REACTIVE PROTEIN; CEFEPIME; CLARITHROMYCIN; COLESTYRAMINE; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; OXYGEN; SALAZOSULFAPYRIDINE;

ABDOMEN; ADULT; AMBIENT AIR; ARTERIAL GAS; ARTICLE; CASE REPORT; COMMUNITY ACQUIRED PNEUMONIA; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DIARRHEA; DRUG WITHDRAWAL; DYSPNEA; FEMALE; FEVER; HUMAN; INTERSTITIAL PNEUMONIA; LIMB; LUNG LAVAGE; LYMPHOCYTE; MACROPHAGE; NASOGASTRIC TUBE; OXYGEN SATURATION; PH; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY; TREATMENT OUTCOME; URTICARIA;

ADULT; ALVEOLITIS, EXTRINSIC ALLERGIC; ANION EXCHANGE RESINS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CHOLESTYRAMINE RESIN; FEMALE; HUMANS; ISOXAZOLES; LUNG DISEASES, INTERSTITIAL;

EID: 74549197192     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3181c3f87e     Document Type: Article

References (15)

1. Boyd IW, et al. Pneumonitis associated with leflunomide: a profile of New Zealand and Australian reports. Intern Med J. 2006;36:162-169.
2. Aventis Pharmaceuticals: Arava (Leflunomide) and interstitial lung disease 21 June 2004. Available at: http://www.hc-sc.gc.ca/dhp-mps/medeff/ advisories-avis/ prof/2004/arava-2-hpc-cps-e.html. Accessed March 13, 2008.
3. Hirabayashi Y, Shimizu H, Kobayashi N, et al. Leflunomide-induced pneumonitis in a patient with rheumatoid arthritis. Intern Med J. 2006; 45:689-691.
4. Kamata Y, Nara H, Kamimura T, et al. Rheumatoid arthritis complicated with acute interstitial pneumonia as an adverse reaction. Intern Med. 2004;43: 1201-1204.
5. Ochi S, Harigai M, Mizoguchi F, et al. Leflunomide-related acute interstitial pneumonia in two patients with rheumatoid arthritis: autopsy findings with a mosaic pattern of acute and organizing diffuse alveolar damage. Mod Rheumatol. 2006;16:316-320.
6. Takeishi M, Akiyama Y, Akiba H, et al. Leflunomide induced acute interstitial pneumonia. J Rheumatol. 2005;32:1160-1163.
7. Lee JH, Cheon WS, Seo YI, et al. A case of interstitial pneumonitis caused by leflunomide. Tuberc Respir Dis. 2005;58:83-88.
8. Vallbracht II, Popper HH, Rieber J, et al. Lethal pneumonitis under leflunomide therapy. Rheumatology. 2005;44:1580-1581.
9. Searles G, McKendry RJ. Methotrexate pneumonitis in rheumatoid arthritis: potential risk factors: 4 case reports and a review of the literature. J Rheumatol. 1987;14:1164-1171.
10. Ju JH, Kim SI, Lee JH, et al. Risk of interstitial lung disease associated with leflunomide treatment in Korean patients with rheumatoid arthritis. Arthritis Rheum. 2007;56:2094-2096.
11. Sakai F, Noma S, Kurihara Y, et al. Leflunomide-related lung injury in patients with rheumatoid arthritis: imaging features. Mod Rheumatol. 2005; 15:173-179.
12. Maddison P, Kiely P, Kirkham B, et al. Leflunomide in rheumatoid arthritis: recommendations through a process of consensus. Rheumatology. 2005;44: 280-286.
13. Suissa S, Hudson M, Ernst P, et al. Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis. Arthritis Rheum. 2006;54:1435-1439.
14. Aventis Pharmaceuticals. Arava (leflunomide) prescribing information Jul 2007. Available at: http://products.sanofi-aventis.us/arava/arava.html#warnings. Accessed March 13, 2008.
15. Hill CL. Leflunomide-induced peripheral neuropathy: rapid resolution with cholestyramine wash-out [letter]. Rheumatology. 2004;43:809.